SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (the “Company”; NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it will host a conference call to discuss the previously announced withdrawal of the proposal to acquire all outstanding shares of the Company. The Company will also provide a preliminary mid-year update on business operations.
